Longeveron Inc.

0.52 USD
-0.01 (-1.45%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Longeveron Inc. stock is down -40.65% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 February’s closed higher than January.

About Longeveron Inc.

Longeveron Inc. develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product. It is conducting Phase 1 and 2 clinical trials in various indications.